Excessivecapital requirement and myriad of other complexities associated with thediscovery of biologics have prompted drug developers to adopt in silico tools /techniques to expedite the discovery timelines
RootsAnalysis is pleased to announce the publication of its recent study, titled, “In Silico / Computer-Aided DrugDiscovery Services Market:Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, GeneTherapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, FragmentBased Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery/ Multi-Target Drug Design, Interface Based Drug Discovery, Approaches).”
The report features an extensive study on thecurrent landscape and the likely future potential of the companies offeringservices for the discovery of large molecule drugs based on the use of insilico tools and techniques. The study features an in-depth analysis,highlighting the capabilities of various industry stakeholders. In addition toother elements, the report includes:
· A detailed assessment of the current marketlandscape of companies offering in silico drug discovery services for largemolecules.
· Elaborate profiles of key industry playersthat offer a wide range of in silico drug discovery services (shortlisted onthe basis of the company size).
· A detailed peer group-based benchmarkinganalysis, comparing the involved players based on several relevant parametersrelated to company and services.
· An insightful competitiveness analysis featuringa four-dimensional bubble chart, highlighting the key players in this domain.
· A detailed analysis assessing the currentopportunity within in silico drug discovery services market.
· A discussion on the various businessstrategies that can be adopted by in silico drug discovery service providers inorder to maintain a competitive edge in this industry.
· An insightful analysis highlighting the costsaving potential associated with the use of in silico approaches in the drugdiscovery process.
· A case study comparing the key challengesassociated with the discovery and production of large molecules.
· Insights from an industry-wide survey,featuring inputs solicited from various experts in this domain.
· A discussion on the upcoming computationalapproaches that are being adopted for drug discovery purposes.
· A case study highlighting severalnon-computational methods / technologies used in drug discovery process.
GetDetailed Research on:
https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
KeyDrug Discovery Steps
· Target Identification
· Target Validation
· Hit Generation
· Hit-to-Lead
· Lead Optimization
Typeof Large Molecule
· Antibodies
· Proteins
· Peptides
· Nucleic Acids
· Vectors
CompanySize
· Small
· Mid-sized
· Large
Targettherapeutic Area
· Autoimmune Disorders
· Blood Disorders
· Cardiovascular Disorders
· Gastrointestinal and Digestive Disorders
· Hormonal Disorders
· Human Immunodeficiency Virus (HIV) / AcquiredImmunodeficiency Syndrome (AIDS)
· Infectious Diseases
· Metabolic Disorders
· Mental Disorders
· Musculoskeletal Disorders
· Neurological Disorders
· Oncological Disorders
· Respiratory Disorders
· Skin Disorders
· Urogenital Disorders
· Others
Typeof Sponsor
· Industry Players
· Non-Industry Players
KeyGeographical Regions
· North America
· Europe
· Asia-Pacific
Transcriptsof interviews held with the following senior level representatives ofstakeholder companies
· John L Kulp (Chief Executive Officer andChief Technical Officer, Conifer Point Pharmaceuticals)
· Sven Benson (Founder, candidum)
· Mark Whittaker (Senior Vice President,Evotec)
· Edelmiro Moman (Scientific Consultant andTeacher, ProSciens)
Keycompanies covered in the report
· Abzena
· BioDuro
· BioNTech
· ChemPartner
· Creative Biostructure
· GenScript
· LakePharma
· Sundia MediTech
· Sygnature Discovery
· Viva Biotech
Formore information, please click on the following link:
https://www.rootsanalysis.com/reports/298/request-sample.html
ChapterOutlines
Chapter1is an executive summary of the key insights captured in our research. It offersa high-level view on the current state of the in silico services market and itslikely evolution in the short-mid term and long term.
Chapter2provides an introduction to the overall drug discovery process, includingdetails on the time taken for a drug to traverse from the bench to the market,and the various stages of the drug discovery process. It also provides anoverview of various in silico drug discovery approaches, and a detailedclassification of computer-aided research tools and techniques. In addition, itfeatures information on the applications of in silico tools across different stepsof the drug discovery process, along with details of specific in silico methods/ approaches associated with these steps. It also highlights the benefits ofthe in silico approach and the key challenges associated with carrying out insilico (including CADD) drug discovery research in-house. Finally, the chapterhighlights the current preference to outsource such operations, especially forlarge molecule drugs.
Chapter3provides an assessment of the global landscape of the in silico servicesmarket. It includes information on over 60 players that are currently engagedin providing such services for discovery of large molecules. It features anin-depth market overview, including information on location of headquarters,employee count, type of business model used (contract service providers,software / technology providers, consulting service providers and trainingservice providers), number of drug discovery step(s) for which the companyoffers services involving the use of in silico approaches (target identification,target validation, hit generation, hit-to-lead and lead optimization), type oflarge molecules(s) handled (antibodies (monoclonal antibodies, bispecificantibodies, polyclonal antibodies, ADCs, antibody fragments, single domainantibodies, antisense antibodies and others), proteins (fusion proteins,protein fragments, enzymes and hormones), peptides, cell therapies, genetherapies, vectors, nucleic acids), type of in silico approach used (SBDD,FBDD, TBDD, LBDD and IBDD), type of in silico service(s) offered (virtualscreening, molecular docking, molecular modeling, scaffold hopping and 8+services), and type of clientele served (pharmaceutical / biotechnologycompanies and academic / research institutes). It also includes the list ofvarious software tools / web applications / technology platforms offered by thein silico service providers for the drug discovery, has been provided.
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
AlsoVisit Our Latest Publication:
Cell Therapy Manufacturing Market Size,2030
Biologics Fill / Finish Services MarketSize, 2030
Vaccine Contract Manufacturing Market Size,2030
mRNA Therapeutics and Vaccines Market Size,2030
Viral Vectors, Non-Viral Vectors and GeneTherapy Manufacturing Market
